News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,084 signal articles · 156 in last 24h · 158,897 total before filter · latest 52m ago

156last 24h

884last 7d

127● bullish (7d)

83● bearish (7d)

214publishers

All Macro195 Earnings177 M&A92 Regulatory16 Product17 Analyst27

✕ clear all filterssentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

Quartz144d agoneutral

Wendy's Q1 2026 earnings beat estimates, U.S. same-store sales fall

The fast-food chain beat adjusted EPS and revenue estimates but U.S. same-restaurant sales dropped 7.8% in what interim CEO Ken Cook called an early-stage turnaround

WEN

InvestorsHub144d agoneutral

Wendy’s (WEN) shares rise after quarterly earnings top expectations

Wendy’s Co (NASDAQ:WEN) shares climbed 4. 3% in premarket trading after the restaurant chain reported first-quarter earnings ahead of Wall Street forecasts, despite continued weakness in its domestic operations.

WEN

Zacks144d agoneutral

Chevron (CVX) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Chevron (CVX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CVX

Zacks144d agoneutral

Howmet (HWM) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Howmet (HWM) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HWM

Motley Fool144d agoneutral

Why Are Some Investors Excited About Meta Platforms After Its Q1 Earnings?

Meta gave investors something important in its latest earnings: Early proof that its AI investments are starting to pay off.

META

Motley Fool145d agoneutral

Gilead (GILD) Q1 2026 Earnings Call Transcript

As we execute on the strongest pipeline in our history, Gilead Sciences, Inc. is also taking steps to further strengthen the company's position for the future. The ongoing success of the Esthugo launch is a key driver of this growth in HIV prevention, with first quarter sales growing 72% sequentially. Looking forward, with no major LOEs until 2036, Gilead Sciences, Inc.'s HIV business is poised for strong, durable growth supported by up to seven potential new HIV product launches by 2033.

GILD

GuruFocus.com145d agoneutral

Tencent Earnings Growth Seen Slowing As AI Investments Double

Tencent and Alibaba face rising AI costs, cloud margin pressure, and tougher competition after DeepSeek's V4 model launch.

BABA

Reuters145d agoneutral

Global equity funds draw inflows for the seventh week on earnings optimism

May 8 () - Global equity funds attracted inflows for a seventh straight week in the period through May 6, supported ‌by upbeat first quarter earnings and hopes for a ‌U.35 billion of global equity funds during the week, though this was the smallest weekly inflow since March 18, LSEG Lipper data showed.

AMD